Screener
Edwards Lifesciences
EWEdwards Lifesciences is a global leader in structural heart innovation, specializing in the development of medical technologies for heart valve disease and critical care monitoring.
Earnings
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$1.7B
EPS estimate$0.73
Financials
Q2 2026Income statement
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Edwards Lifesciences is a global leader in structural heart innovation, specializing in the development of medical technologies for heart valve disease and critical care monitoring. The company focuses on transformative product innovation and high-quality clinical evidence to provide both surgical and transcatheter therapies for aortic, mitral, tricuspid, and pulmonic heart valves.
Competitive position
Edwards is the global market leader in transcatheter aortic valve replacement and a pioneer in surgical tissue heart valves.
GeographiesUnited States, Europe, Japan, Rest of World
Customer segmentsHospitals, Specialized Medical Clinics, Healthcare Systems
Business modelMedical Device Manufacturing, Direct Sales, R&D Driven
SuppliersBovine and porcine tissue suppliers, Specialized medical-grade polymers and metals, Electronic component manufacturers for monitoring consoles
CustomersAcute care hospitals, Cardiac catheterization laboratories, Government healthcare providers, Private insurance payers
CountryUnited States of America
Listed2000
Employees19.8K
CEOBernard J. Zovighian
SectorHealthcare
IndustryMedical - Devices
Websiteedwards.com
FilingsSEC EDGAR
FAQ
- What is Edwards Lifesciences's market cap?
- Edwards Lifesciences (EW) has a market capitalization of $52.3B and trades on NYSE.
- What is Edwards Lifesciences's revenue and profitability?
- Edwards Lifesciences generated $6.5B in trailing twelve-month revenue with net income of $1.0B, representing a net margin of 15.4%. Gross margin stands at 77.8%. These figures are based on the Q2 2026 filing.
- Who are Edwards Lifesciences's competitors?
- Edwards Lifesciences's key competitors include Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- Where is Edwards Lifesciences headquartered?
- Edwards Lifesciences is headquartered in United States of America and employs approximately 19,800 people. It has been publicly traded since 2000.
